Literature DB >> 11580951

Radiosurgery of cavernous hemangiomas in the cavernous sinus.

Y Kida1, T Kobayashi, Y Mori.   

Abstract

BACKGROUND: Cavernous hemangiomas in the cavernous sinus are rare and demonstrate unique clinical courses. Although they rarely cause spontaneous bleeding, serious bleeding is not uncommon during operations. Total eradication of such tumors is very difficult because of the location and intraoperative bleeding. Consequently, alternatives to operative resection have been examined.
METHODS: Three cases of cavernous hemangiomas in the cavernous sinus, presenting chiefly with ocular signs and facial pain, were treated by radiosurgery using a gamma knife. Two of the patients had been operated on before radiosurgery, while the third patient was diagnosed on the basis of neurological signs as well as radiological findings.
RESULTS: MRI scans at the time of radiosurgery showed tumors in the cavernous sinus with low or iso-intensity on T1-weighted images and high signal intensity on T2-weighted images. All of the tumors intensely enhanced with gadolinium-DTPA. The tumors had diameters of 14 to 28 mm and were treated with a marginal dose of 14 to 17 Gy (mean 15.7 Gy). In the mean follow-up period of 27 months after radiosurgery, all of the tumors decreased in size (PR). Neurologically, none of the patients showed any deterioration, and one demonstrated an obvious improvement in ocular movement.
CONCLUSIONS: Radiosurgery for cavernous hemangioma in the cavernous sinus is apparently safe and effective with consistent tumor shrinkage. Therefore, radiosurgery is an excellent alternative to operative intervention and may even replace operative procedures if the tumors are small in diameter or when they recur.

Entities:  

Mesh:

Year:  2001        PMID: 11580951     DOI: 10.1016/s0090-3019(01)00537-7

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

Review 1.  Parasellar syndromes.

Authors:  Janine L Johnston
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  Cavernous sinus haemangioma with intrasellar extension mimicking non-functioning pituitary adenoma - A case report and review of literature.

Authors:  Dorota Księżniak-Baran; Sławomir Blamek; Agata Roch-Zniszczoł; Wojciech Osewski; Maja Jędrzejewska
Journal:  Rep Pract Oncol Radiother       Date:  2019-08-01

3.  Gamma Knife radiosurgery for the treatment of cavernous sinus hemangiomas.

Authors:  Qingsheng Xu; Jian Shen; Yiping Feng; Renya Zhan
Journal:  Oncol Lett       Date:  2015-12-23       Impact factor: 2.967

Review 4.  The role of stereotactic radiosurgery in cavernous sinus hemangiomas: a systematic review and meta-analysis.

Authors:  Xin Wang; Guanghai Mei; Xiaoxia Liu; Jiazhong Dai; Li Pan; Enmin Wang
Journal:  J Neurooncol       Date:  2011-11-16       Impact factor: 4.130

5.  Stereotactic radiosurgery for hypervascular intracranial tumors.

Authors:  Cheng-Chia Lee; Chun-Lung Chou; Ching-Jen Chen; Huai-Che Yang; Hsiu-Mei Wu; Cheng-Ying Shiau; David Hung-Chi Pan; Wen-Yuh Chung
Journal:  J Neurooncol       Date:  2018-08-20       Impact factor: 4.130

6.  Evaluation of Skull Base Tumors with Dynamic TurboFLASH MRI during Gadolinium Injection.

Authors:  Guido Trasimeni; Marina Auconi; Andrea Grossi; Olga Gagliardo; Andrea Romano; Edoardo Covelli; Alessandro Bozzao
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-15

Review 7.  Safety and efficacy of single-fraction gamma knife radiosurgery for benign confined cavernous sinus tumors: our experience and literature review.

Authors:  Manjul Tripathi; Aman Batish; Narendra Kumar; Chirag Kamal Ahuja; Arun S Oinam; Rupinder Kaur; Rajasekhar Narayanan; Jenil Gurnaani; Amanjot Kaur
Journal:  Neurosurg Rev       Date:  2018-04-09       Impact factor: 3.042

8.  Transnasal endoscopic resection of a cavernous sinus hemangioma: technical note and review of the literature.

Authors:  Justin F Fraser; Alon Y Mass; Seth Brown; Vijay K Anand; Theodore H Schwartz
Journal:  Skull Base       Date:  2008-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.